212 related articles for article (PubMed ID: 15674339)
21. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
[TBL] [Abstract][Full Text] [Related]
22. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
23. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
24. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
25. Pagetoid spread of intratubular germ cell neoplasia into rete testis: a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors.
Perry A; Wiley EL; Albores-Saavedra J
Hum Pathol; 1994 Mar; 25(3):235-9. PubMed ID: 7512072
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
28. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
Besson A; Robbins SM; Yong VW
Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
30. Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer.
Orikasa K; Fukushige S; Hoshi S; Orikasa S; Kondo K; Miyoshi Y; Kubota Y; Horii A
J Hum Genet; 1998; 43(4):228-30. PubMed ID: 9852672
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
Tolkacheva T; Chan AM
Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis.
Houldsworth J; Reuter V; Bosl GJ; Chaganti RS
Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671
[TBL] [Abstract][Full Text] [Related]
33. Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors.
Franke FE; Pauls K; Kerkman L; Steger K; Klonisch T; Metzger R; Alhenc-Gelas F; Burkhardt E; Bergmann M; Danilov SM
Hum Pathol; 2000 Dec; 31(12):1466-76. PubMed ID: 11150371
[TBL] [Abstract][Full Text] [Related]
34. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
[TBL] [Abstract][Full Text] [Related]
35. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
36. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
Moritake H; Horii Y; Kuroda H; Sugimoto T
Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
[TBL] [Abstract][Full Text] [Related]
37. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
38. [CD143 expression in testicular germ cell tumors].
Franke FE; Pauls K; Kerkman L; Steger K; Fink L; Burkhardt E; Klonisch T; Bergmann M; Danilov SM
Verh Dtsch Ges Pathol; 2000; 84():199-209. PubMed ID: 11217441
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutation of PTEN in bladder carcinoma.
Aveyard JS; Skilleter A; Habuchi T; Knowles MA
Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673
[TBL] [Abstract][Full Text] [Related]
40. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
